[1] Buemi, M.R.; De Luca, L.; Chimirri, A.; Ferro, S.; Gitto, R.; Alvarez-Builla, J.; Alajarin, R. Indole derivatives as dual-effective agents for the treatment of neurodegenerative diseases: Synthesis, biological evaluation, and molecular modelling studies. Bioorg. Med. Chem., 2013, 21, 4575-4580.
[2] Silveira, C.C.; Mendes, S.R.; Soares, J.R.; Victoria, F.N.; Martinez, D.M. Synthesis and antioxidant activity of new C-3 sulfenyl indoles. Tetrahedron Lett., 2013, 54, 4926-4929.
[3] Talaz, O.; Gülçin, I.; Göksu, S.; Saracoglu, N. Antioxidant activity of 5,10-dihydroindeno[1,2-b]indoles containing substituents on dihydroindeno part. Bioorg. Med. Chem., 2009, 17, 6583-6589.
[4] Sashidara, K.V.; Kumar, M.; Sonkar, R.; Singh, B.S.; Khanna, A.K.; Bhatia, G. Indole-based fibrates as potential hypolipidemic antiobesity agents. J. Med. Chem., 2012, 55, 2769-2779.
[5] Chang, H.; Wang, M.; Chan, M.; Chiu, Y.; Chen, Y. Antiobesity activities of indole-3-carbinol in high-fat-diet-induced obese mice. Nutrition, 2011, 27, 463-470.
[6] Agarwal, A.; Srivastava, K.; Puri, S.K.; Chauhan, P.M.S. Synthesis of substituted indole derivatives as a new class of antimalarial agents. Bioorg. Med. Chem. Lett., 2005, 15, 3133-3136.
[7] Kgokong, J.L.; Smith, P.P.; Matsabisa, G.M. 1,2,4-Triazino-[5,6b]indole derivatives: effects of the trifluoromethyl group on in vitro antimalarial activity. Bioorg. Med. Chem. Lett., 2005, 13, 2935-2942.
[8] Winter, C.A.; Risley, E.A., Nuss, G.W. Anti-inflammatory and antipyretic activities of indomethacin, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-indole-3-acetic acid. J. Pharmcol. Exp. Ther., 1963, 141, 369-376.
[9] Oliva, B.; Miller, K.; Caggiano, N.; O’Neill, A.J.; Cuny, G.D.; Hoemann, M.Z.; Hauske, J.R.; Chopra, I. Biological properties of novel antistaphylococcal quinolone-indole agents. Antimicrob. Agents Chemother., 2003, 47(2), 458-466.
[10] Berlin, W.; Sauer, B. In situ color detection of alpha-L-arabinofuranosidase, a “no-background” reporter gene, with 5-bromo-3-indolyl-alpha-L-arabinofuranoside. Anal. Biochem. 1996, 243, 171-5.
[11] Bovill, R.; Druggan, P. The use of chromogenic enzyme substrates in microbial identification. Culture, 2005, 26, 2, 5-8.
[12] Rodríguez-Domínguez, J.C.; Balbuzano-Deus, A.; López-López, M.A.; Kirsch, G. An improved synthesis of 1-acetyl-1H-indol-3-yl acetates. J. Heterocyclic Chem., 2007, 44, 273-275.
[13] Guyen, B.; Schultes, C.M.; Hazel, P.; Mann, J.; Neidle, S. Synthesis and evaluation of analogues of 10H-indolo[3,2-b]quinolone as G-quadruplex stabilising ligands and potential inhibitors of the enzyme telomerase. Org. Biomol. Chem., 2004, 2, 981-988.
[14] Lai, T.K.; Chatterjee, A.; Banerji, J.; Sarkar, D.; Chattopadhyay, N. A concise synthesis of the DNA-intercalating and antimalarial alkaloid cryptolepine and its fluorescence behavior in solvents of different polarities. Helv. Chim. Acta, 2008, 91, 1975-1983.
[15] Choi, S.; Lee, J.; Jeong, S.; Im, I.; Lee, S.; Lee, E.; Lee, S.K.; Kwon, S.; Ahn, S.; Yoon, J.; Han, S.; Kim, J.; Kim, Y. 5,5’-Substituted indirubin-3’-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activity. J. Med. Chem., 2010, 53, 3696-3706.